Ślusarz Robert, Biercewicz Monika, Smarszcz Barbara, Szewczyk Maria, Rosińczuk Joanna, Śniegocki Maciej
Neurological and Neurosurgical Nursing Department, Faculty of Health Sciences, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland.
Clinic of Geriatrics, Faculty of Health Sciences, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland.
Adv Clin Exp Med. 2017 Sep;26(6):981-986. doi: 10.17219/acem/61832.
While data on the long-term (e.g., 1 year and subsequent years) outcomes of intracranial aneurysms treatment is relatively well-documented mainly in the clinical aspect (comparability of treatment, mortality, and complications), little is known about the early results, in terms of the functional outcome.
The aim of the study was to analyze the use of Functional Capacity Scale (FCS) in the evaluation of patients in the early period after endovascular treatment of intracranial aneurysms.
The study was conducted in the Neurosurgery Clinic, University Hospital Collegium Medicum in Bydgoszcz, on a group of 118 consecutively admitted patients with the diagnosis of intracranial aneurysm, qualified for treatment using the endovascular method (embolization). The assessment was performed twice. In the clinical assessment the Glasgow Coma Scale (GCS) was used to evaluate the level of consciousness and the Hunt and Hess Scale (H&H) to assess the patient's condition. To assess the final outcome and early functional capacity Glasgow Outcome Scale (GOS), Barthel Index (BI), Modified Rankin Scale (mRS) and the new Functional Capacity Scale were used.
The assessment performed with the FCS was comparable to the assessment conducted with standardized tools such as BI, mRS or GOS. The clinical condition assessed with the GCS (p < 0.001) and H&H (p < 0.001) differentiates the functional condition assessed using the FCS. Statistically significant correlations were found between FCS and BI (r = -0.78), GOS (r = -0.69) and mRS (r = 0.68).
The study indicates that the FCS correlates with other scales used in the assessment of patients with intracranial aneurysm, which means that the proposed tool can be applied successfully in practice. However, further randomized multicenter studies are necessary in order to clarify the final conclusion.
虽然颅内动脉瘤治疗的长期(如1年及以后)结果的数据在临床方面(治疗的可比性、死亡率和并发症)记录相对完善,但在功能结果方面,关于早期结果却知之甚少。
本研究的目的是分析功能能力量表(FCS)在颅内动脉瘤血管内治疗后早期患者评估中的应用。
本研究在比得哥什大学医院医学院神经外科诊所进行,对118例连续收治的诊断为颅内动脉瘤且符合血管内治疗(栓塞)条件的患者进行研究。评估进行了两次。在临床评估中,使用格拉斯哥昏迷量表(GCS)评估意识水平,使用亨特和赫斯量表(H&H)评估患者状况。为评估最终结果和早期功能能力,使用了格拉斯哥预后量表(GOS)、巴氏指数(BI)、改良Rankin量表(mRS)和新的功能能力量表。
用FCS进行的评估与用BI、mRS或GOS等标准化工具进行的评估具有可比性。用GCS(p<0.001)和H&H(p<0.001)评估的临床状况区分了用FCS评估的功能状况。FCS与BI(r = -0.78)、GOS(r = -0.69)和mRS(r = 0.68)之间存在统计学显著相关性。
该研究表明,FCS与用于评估颅内动脉瘤患者的其他量表相关,这意味着所提出的工具可以在实践中成功应用。然而,需要进一步的随机多中心研究以阐明最终结论。